These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 66832)

  • 21. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
    Molnár Z; Fleischmann T
    Orv Hetil; 1992 Jun; 133(25):1561-3. PubMed ID: 1383902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
    Diehl V
    J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
    [No Abstract]   [Full Text] [Related]  

  • 27. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH; Corder MP
    Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
    [No Abstract]   [Full Text] [Related]  

  • 28. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Klener P; Donner L
    Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RC; Berard C; DeVita VT
    Blood; 1974 Feb; 43(2):181-9. PubMed ID: 4589318
    [No Abstract]   [Full Text] [Related]  

  • 31. [Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
    Tursz T; Ben Ayed F; Droz JP; Spielmann M; Amiel JL
    Bull Cancer; 1982; 69(1):28-32. PubMed ID: 6176284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
    Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ;
    N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
    Schmidt CG
    Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
    Koza I; Bohunický L; Mociková K; Gyárfás J; Svancárová L; Mardiak J; Spánik S; Fuchsberger P; Thalmeinerová Z; Sufliarsky J
    Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy of malignant lymphomas].
    Brücher H
    Med Welt; 1978 Oct; 29(40):1563-9. PubMed ID: 360002
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination.
    Wittes RE; Wittes JT; Golbey RB
    Cancer; 1978 Feb; 41(2):415-21. PubMed ID: 343907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Greater curability in advanced Hodgkin's disease?
    Portlock CS
    Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.